{"id":"https://openalex.org/W2124367348","doi":"https://doi.org/10.1158/1538-7445.am2013-2072","title":"Abstract 2072: SNDX-275 synergistically inhibits the growth of sarcoma cells when combined with AKT inhibitors, platinum drugs and Topo II poisons.","display_name":"Abstract 2072: SNDX-275 synergistically inhibits the growth of sarcoma cells when combined with AKT inhibitors, platinum drugs and Topo II poisons.","publication_year":2013,"publication_date":"2013-04-01","ids":{"openalex":"https://openalex.org/W2124367348","doi":"https://doi.org/10.1158/1538-7445.am2013-2072","mag":"2124367348"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am2013-2072","doi":"https://doi.org/10.1158/1538-7445.am2013-2072","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2013-2072","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5036862186","display_name":"Christopher L. Cubitt","orcid":"https://orcid.org/0000-0001-6343-7451","observed_orcids":["https://orcid.org/0000-0001-6343-7451"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Christopher L. Cubitt","raw_affiliation_strings":["1Moffitt Cancer Center & Research Institute, Tampa, FL;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Moffitt Cancer Center & Research Institute, Tampa, FL;","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008113532","display_name":"Jillaina L. Menth","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jillaina Menth","raw_affiliation_strings":["1Moffitt Cancer Center & Research Institute, Tampa, FL;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Moffitt Cancer Center & Research Institute, Tampa, FL;","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035721135","display_name":"Jana L. Dawson","orcid":"https://orcid.org/0000-0002-4901-0897","observed_orcids":["https://orcid.org/0000-0002-4901-0897"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jana Dawson","raw_affiliation_strings":["1Moffitt Cancer Center & Research Institute, Tampa, FL;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Moffitt Cancer Center & Research Institute, Tampa, FL;","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103705497","display_name":"John M. Goldberg","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I145608581","display_name":"University of Miami","ror":"https://ror.org/02dgjyy92","country_code":"US","type":"education","lineage":["https://openalex.org/I145608581"]},{"id":"https://openalex.org/I4210118328","display_name":"University of Miami Hospital","ror":"https://ror.org/02yx0mh38","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I145608581","https://openalex.org/I4210101935","https://openalex.org/I4210118328"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"John M. Goldberg","raw_affiliation_strings":["2Holtz Children's Hospital University of Miami Miller School of Medicine, Miami, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Holtz Children's Hospital University of Miami Miller School of Medicine, Miami, FL","institution_ids":["https://openalex.org/I145608581","https://openalex.org/I4210118328"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029966550","display_name":"Damon R. Reed","orcid":"https://orcid.org/0000-0002-8238-2465","observed_orcids":["https://orcid.org/0000-0002-8238-2465"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Damon Reed","raw_affiliation_strings":["1Moffitt Cancer Center & Research Institute, Tampa, FL;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Moffitt Cancer Center & Research Institute, Tampa, FL;","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5102841436","display_name":"Daniel M. Sullivan","orcid":"https://orcid.org/0009-0003-0951-9781","observed_orcids":["https://orcid.org/0009-0003-0951-9781","https://orcid.org/0000-0002-2183-1773"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Daniel M. Sullivan","raw_affiliation_strings":["1Moffitt Cancer Center & Research Institute, Tampa, FL;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Moffitt Cancer Center & Research Institute, Tampa, FL;","institution_ids":["https://openalex.org/I3019308854"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"73","issue":"8_Supplement","first_page":"2072","last_page":"2072"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11736","display_name":"Histone Deacetylase Inhibitors Research","score":0.9477999806404114,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11736","display_name":"Histone Deacetylase Inhibitors Research","score":0.9477999806404114,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10253","display_name":"Sarcoma Diagnosis and Treatment","score":0.04820000007748604,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12820","display_name":"Chromatin Remodeling and Cancer","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/histone-deacetylase-inhibitors","display_name":"histone deacetylase inhibitors","score":0.8370000123977661},{"id":"https://openalex.org/keywords/sarcoma","display_name":"sarcoma","score":0.8500000238418579},{"id":"https://openalex.org/keywords/osteosarcoma","display_name":"osteosarcoma","score":0.8289999961853027},{"id":"https://openalex.org/keywords/akt-inhibitors","display_name":"AKT inhibitors","score":0.7409999966621399},{"id":"https://openalex.org/keywords/mk-2206","display_name":"MK-2206","score":0.9620000123977661},{"id":"https://openalex.org/keywords/trichostatin-a","display_name":"trichostatin A","score":0.8320000171661377},{"id":"https://openalex.org/keywords/carboplatin","display_name":"carboplatin","score":0.9860000014305115},{"id":"https://openalex.org/keywords/cisplatin","display_name":"cisplatin","score":0.9819999933242798},{"id":"https://openalex.org/keywords/etoposide","display_name":"etoposide","score":0.996999979019165},{"id":"https://openalex.org/keywords/topoisomerase-ii-poisons","display_name":"topoisomerase II poisons","score":0.847000002861023},{"id":"https://openalex.org/keywords/drug-synergy","display_name":"drug synergy","score":0.7120000123977661},{"id":"https://openalex.org/keywords/combination-index","display_name":"combination index","score":0.7149999737739563},{"id":"https://openalex.org/keywords/vorinostat","display_name":"vorinostat","score":0.7799999713897705}],"concepts":[{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.6314029693603516},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5220943689346313},{"id":"https://openalex.org/C2776999253","wikidata":"https://www.wikidata.org/wiki/Q1304270","display_name":"Combination therapy","level":2,"score":0.4488631784915924},{"id":"https://openalex.org/C2776262904","wikidata":"https://www.wikidata.org/wiki/Q905901","display_name":"Vorinostat","level":5,"score":0.4376399517059326},{"id":"https://openalex.org/C53227056","wikidata":"https://www.wikidata.org/wiki/Q189152","display_name":"Viability assay","level":3,"score":0.41980403661727905},{"id":"https://openalex.org/C75217442","wikidata":"https://www.wikidata.org/wiki/Q423650","display_name":"Protein kinase B","level":3,"score":0.4183601438999176},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.405289888381958},{"id":"https://openalex.org/C190283241","wikidata":"https://www.wikidata.org/wiki/Q14599311","display_name":"Apoptosis","level":2,"score":0.3771073520183563},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.30319881439208984},{"id":"https://openalex.org/C2778305200","wikidata":"https://www.wikidata.org/wiki/Q174378","display_name":"Histone deacetylase","level":4,"score":0.23934033513069153},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.08181595802307129},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0},{"id":"https://openalex.org/C64927066","wikidata":"https://www.wikidata.org/wiki/Q36293","display_name":"Histone","level":3,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.am2013-2072","doi":"https://doi.org/10.1158/1538-7445.am2013-2072","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2013-2072","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9789000153541565,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2329997149","https://openalex.org/W2560371191","https://openalex.org/W1986350942","https://openalex.org/W2475420094","https://openalex.org/W2791766524","https://openalex.org/W2093817700","https://openalex.org/W2320741374","https://openalex.org/W2024804801","https://openalex.org/W2558950888","https://openalex.org/W1994767036"],"abstract_inverted_index":{"Abstract":[0],"The":[1,205],"number":[2],"of":[3,10,22,59,63,131,156,176,191,199,207,245,264,427,444,449],"effective":[4,220],"drugs":[5,110,436],"available":[6],"for":[7,89,94,223,248,453],"the":[8,33,57,109,113,154,181,189,197,228,262,425,445,450],"treatment":[9,221,257],"soft":[11],"tissue":[12],"and":[13,47,74,105,123,167,196,234,236,437],"bone":[14],"sarcomas":[15],"is":[16],"limited":[17],"to":[18,85,99,187],"a":[19,136,163,212],"small":[20],"group":[21],"antineoplastic":[23],"agents.":[24],"Previously,":[25],"we":[26,55],"have":[27],"identified":[28],"synergistic":[29,116,137,140,169],"anti-tumor":[30],"activities":[31],"when":[32,69,170,430],"HDAC":[34,50,64],"inhibitor":[35,62],"Vorinostat":[36],"was":[37,147,160,178],"used":[38,179],"in":[39,106,112,118,142,149,153,180,251],"combination":[40,107,214,272],"with":[41,71,108,432],"FDA":[42,76],"approved":[43,77],"chemotherapies.":[44],"With":[45],"newer":[46],"more":[48],"selective":[49],"inhibitors":[51,73],"entering":[52],"clinical":[53],"trials":[54],"examined":[56],"effectiveness":[58],"SNDX-275,":[60],"an":[61,219],"I,":[65],"II":[66,439],"&":[67,134],"III":[68],"combined":[70,431],"Akt":[72],"other":[75],"drugs.":[78],"CT-Blue":[79],"cell":[80,143,157,289],"viability":[81,119,144],"experiments":[82,184],"were":[83],"performed":[84],"first":[86],"obtain":[87],"IC50s":[88,93,233],"72":[90,255],"hour":[91,256],"treatments.":[92],"SNDX-275":[95,103,177,192,216,246,269,281,422],"ranged":[96],"from":[97,267],"0.84":[98,351],"11.4":[100,339],"\u03bcM":[101,175],"(Table).":[102],"alone":[104],"listed":[111],"Table":[114],"showed":[115],"cooperativity":[117],"experiments.":[120],"Using":[121],"Chou":[122,235],"Talalay's":[124],"Combination":[125,238],"Index":[126,239],"(CI)":[127,240],"analyses":[128],"(ED":[129],"levels":[130],"0.7,":[132],"0.9":[133],"0.95),":[135],"or":[138],"strongly":[139],"reduction":[141,250],"(CI":[145],"<0.7)":[146],"observed":[148,161],"most":[150],"combinations":[151,193],"tried":[152],"majority":[155],"lines.":[158],"Synergy":[159,241],"over":[162],"wide":[164],"dose":[165],"range":[166],"remained":[168],"as":[171,173],"little":[172],"0.5":[174],"combination.":[182],"Ongoing":[183],"are":[185],"underway":[186],"identify":[188],"effects":[190],"on":[194,202],"apoptosis":[195],"effect":[198],"drug":[200,213],"sequencing":[201],"growth":[203,426],"inihibition.":[204],"results":[206],"this":[208],"study":[209],"indicate":[210,276],"that":[211],"including":[215],"may":[217],"be":[218],"regimen":[222],"sarcoma":[224,287,428],"patients.":[225],"Funded":[226],"by":[227],"Pediatric":[229],"Cancer":[230,454,464],"Foundation.":[231],"Table.":[232],"Talalay":[237],"Analysis.":[242],"Inhibitory":[243],"concentration":[244],"required":[247],"50%":[249],"viable":[252],"cells":[253,429],"after":[254],"(IC50).":[258],"CI":[259,278,293,295,297,299,301],"values":[260],"represent":[261],"level":[263],"synergy":[265,279],"resulting":[266],"concurrent":[268],"plus":[270],"indicated":[271],"treatment.":[273],"+/-":[274],"symbols":[275],"calculated":[277],"level.":[280],"MK-2206":[282],"Triciribine":[283],"Carboplatin":[284],"Cisplatin":[285],"Etoposide":[286],"type":[288,337],"line":[290],"IC50":[291],"(\u03bcM)":[292],"Syn":[294,296,298,300,302],"osteosarcoma":[303],"MNNG":[304],"HOS":[305],"4.9":[306],"0.393":[307],"+++":[308,310,322,324,329,331,341,357,359,368,372,387,389,391,393],"0.384":[309],"0.214":[311],"++++":[312,316,345,353,355,385,398,404],"0.037":[313],"+++++":[314,343,366,376,378,400,402],"0.252":[315],"U2-OS":[317],"1.8":[318],"1.025":[319],"+/\u2212":[320,333,349,380],"0.391":[321],"0.379":[323],"rhabdomyosarcoma":[325],"A-204":[326],"2.4":[327],"0.305":[328],"0.328":[330],"0.908":[332],"0.815":[334],"++":[335,374],"Ewing":[336],"A-673":[338],"0.350":[340],"0.029":[342,365],"0.185":[344],"RD-ES":[346],"1.5":[347],"0.962":[348],"SK-ES-1":[350],"0.284":[352],"0.293":[354],"0.459":[356],"0.593":[358],"1.278":[360],"\u2212\u2212":[361],"leiomyosarcoma":[362],"SK-LMS-1":[363],"4.3":[364],"0.510":[367],"SK-UT-1":[369],"3.4":[370],"0.332":[371],"0.845":[373],"0.099":[375],"0.082":[377],"0.985":[379],"liposarcoma":[381],"SW-872":[382],"1.6":[383],"0.286":[384],"0.540":[386],"0.511":[388],"0.457":[390],"0.617":[392],"fibrosarcoma":[394],"HT-1080":[395],"5.7":[396],"0.179":[397],"0.060":[399],"0.038":[401],"0.267":[403],"Citation":[405],"Format:":[406],"Christopher":[407],"L.":[408],"Cubitt,":[409],"Jillaina":[410],"Menth,":[411],"Jana":[412],"Dawson,":[413],"John":[414],"M.":[415,420],"Goldberg,":[416],"Damon":[417],"Reed,":[418],"Daniel":[419],"Sullivan.":[421],"synergistically":[423],"inhibits":[424],"AKT":[433],"inhibitors,":[434],"platinum":[435],"Topo":[438],"poisons.":[440],"[abstract].":[441],"In:":[442],"Proceedings":[443],"104th":[446],"Annual":[447],"Meeting":[448],"American":[451],"Association":[452],"Research;":[455],"2013":[456],"Apr":[457],"6-10;":[458],"Washington,":[459],"DC.":[460],"Philadelphia":[461],"(PA):":[462],"AACR;":[463],"Res":[465],"2013;73(8":[466],"Suppl):Abstract":[467],"nr":[468],"2072.":[469],"doi:10.1158/1538-7445.AM2013-2072":[470]},"counts_by_year":[],"updated_date":"2026-10-16T09:59:22.235173","created_date":"2016-06-24T00:00:00"}